BAT stock trades steadily as earnings and dividend support valuation

BAT stock, representing British American Tobacco plc (ISIN GB0002875804), continues to be underpinned by sizeable cash flows and a consistent dividend stream, even as the group navigates regulatory change and evolving consumer preferences in global nicotine markets. The London listed group reported strong revenue and profit figures for fiscal 2023, alongside detailed guidance for 2024 and an ongoing focus on reducing leverage according to its investor materials dated 7 March 2024 on BAT's investor website. For investors, the combination of earnings resilience, debt reduction and a high dividend payout remains central to how BAT stock is valued in comparison with global consumer staples peers.

Revenue up in 2023

According to BAT's annual reporting for fiscal 2023, the group generated reported revenue of around £27.28 billion, marking an increase versus the prior year period and reflecting the impact of pricing, mix and the performance of reduced risk product categories as outlined in the 2023 annual report available via BAT investor documents. In comparison, BAT had reported revenue of approximately £27.65 billion for fiscal 2022 on a reported basis, with management emphasizing constant currency growth alongside foreign exchange headwinds, so the 2023 figure is broadly in line with the prior year on a reported basis while underlying performance showed growth when currency effects are adjusted. The group also highlighted that New Category revenue, including vapor, tobacco heating products and modern oral nicotine, exceeded £3 billion in 2023, up strongly from the prior year level of just over £2.9 billion, underscoring the strategic importance of these segments within BAT's long term plan.

In fiscal 2023 BAT reported adjusted profit from operations of roughly £12.5 billion, compared with an adjusted profit figure in the region of £12.4 billion in fiscal 2022, as described in the annual results materials accessible from BAT's earnings release section. That represents a modest increase year on year and reflects operational efficiencies and pricing actions amid volume declines in some traditional combustibles markets. On an adjusted earnings per share basis, BAT has communicated figures in the region of 330p for 2023 compared with adjusted EPS close to 325p in 2022, indicating low single digit percentage growth despite macroeconomic and regulatory challenges.

Dividend and cash flow metrics

Dividend income is a key pillar for BAT stock holders, and the company maintained a substantial cash return in fiscal 2023. BAT's board recommended a total dividend of roughly 230.9p per share for 2023, split across quarterly payments, compared with a total dividend of about 226.0p per share for 2022 as described in the dividend policy materials on BAT's investors site. The increase of nearly 4.9p represents growth of a little more than 2%, broadly aligned with the firm’s progressive dividend policy while still allowing room for deleveraging and investment in New Categories.

In terms of cash generation, BAT reported operating cash flow in excess of £9 billion for 2023, slightly above the prior year figure which had been in the high £8 billion range according to summary data contained in the cash flow section of BAT's annual report via investor documents. Free cash flow after capital expenditure remained strong, supporting both dividend payments and continued reduction of net debt. BAT indicated that net debt to adjusted EBITDA had fallen to near 2.9 times at the end of 2023, compared with around 3.0 times one year earlier, reflecting incremental progress toward its medium term leverage target.

Management has emphasized capital discipline by balancing shareholder distributions with investments in harm reduction and innovation. According to BAT's guidance comments for fiscal 2024 available through its investor presentations on BAT investor presentations, the company aims for mid single digit growth in constant currency revenue and high single digit growth in adjusted EPS over the medium term, driven by continued momentum in New Categories and resilience in combustible tobacco cash flows.

New Categories exceed £3 billion

BAT's strategy centers on transforming its portfolio toward reduced risk products while actively managing its legacy combustibles business. In its 2023 reporting BAT stated that New Category revenue now exceeds £3 billion and is on track to reach a £5 billion annual revenue target by 2025, as referenced in strategic presentations available via BAT strategy documents. This New Category performance compares with less than £2 billion of revenue only a few years earlier, illustrating a rapid scale up of vapor, tobacco heating and modern oral products.

The company has highlighted that in 2023 it added millions of new consumers in New Categories, contributing to the revenue increase, and has targeted profitability for these segments by 2024. Gross margin development remains important, because New Category products typically require intensive marketing and innovation investment before maturing into cash generators. According to BAT’s commentary, constant currency revenue growth in New Categories was above 20% for 2023, an acceleration compared with growth in the mid teens in 2022 as indicated in the performance summary on BAT’s overview section. For investors this growth helps offset declines in traditional cigarettes volumes in some markets, though regulatory risks and competition remain.

At the same time BAT continues to generate the majority of its profits from combustibles, and management places strong emphasis on defending market share and optimizing pricing. In 2023 BAT indicated global cigarette and fine cut volumes declined selectively, but the group achieved price and mix improvements sufficient to support revenue stability, aligning with trends seen among other large tobacco peers. The combination of stable combustibles cash flows and rising New Category revenue helps build a diversified earnings base, which is one reason the overall valuation multiples for BAT stock often sit below higher growth consumer staples yet above some more mature tobacco names.

Representative product line: Vuse vapor brand

One of BAT's flagship reduced risk product families is the Vuse vapor brand, which the company positions as a central pillar of its New Category portfolio. According to BAT’s product and brand information pages and investor presentations available via BAT investor content, Vuse has achieved leading market share positions in several key markets, including parts of the United States and Western Europe, and contributes meaningfully to New Category revenue growth.

BAT has communicated that Vuse volumes and revenue grew double digits in 2023, helping New Categories exceed the £3 billion revenue threshold, although precise brand level numbers are embedded within segment totals rather than disclosed separately. Product innovation, range extension and the rollout of next generation device platforms remain active areas of investment. For BAT stock holders, the performance of the Vuse brand is not only a driver of revenue growth but also a barometer of the group’s ability to shift consumers toward potentially less harmful alternatives while protecting overall nicotine franchise value.

BAT stock valuation and price context

BAT shares trade primarily on the London Stock Exchange under ticker LSE: BATS, and the group is a constituent of the FTSE 100 index, reflecting its status as one of the larger companies in the United Kingdom by market capitalization. According to data presented on major financial portals and exchange information pages for BAT, the company’s market capitalization has been hovering in the region of £55 billion to £60 billion in recent months, measured as of early 2024, which places BAT among the more substantial names in the global tobacco space and within the wider consumer staples universe of large cap issuers.

During early 2024 BAT stock traded in a 52 week range broadly between about 2,200p and 3,000p per share, with a recent price level in the mid 2,400p to 2,600p band according to quote information on leading market data platforms and LSE price history pages. That price band translates into a trailing price to earnings ratio in the high single digits when set against the adjusted EPS figure of approximately 330p per share for 2023 mentioned earlier. The implied dividend yield, based on the roughly 230.9p total dividend and a share price around 2,500p, stands close to 9%, which remains elevated compared with many consumer staples and broader market benchmarks.

This valuation reflects a mix of perceived regulatory risk, long term volume decline expectations in combustibles, and the potential upside from New Category growth. Some analysts view the combination of high yield and New Category momentum as a support for BAT stock, while others emphasize litigation and regulatory uncertainties, particularly in markets such as the United States where flavor bans or nicotine caps could affect future trajectories. Nevertheless, BAT’s commitment to deleveraging, progressive dividends and strategic pivot toward reduced risk offerings continues to shape investor debate about the appropriate valuation multiple.